Cytosorbents CorporationCTSONASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank87
5Y CAGR+4.3%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

5Y CAGR
+4.3%/yr
Long-term compound
Percentile
P87
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.73M+130.8%
2024$-5.62M-397.9%
2023$1.89M+179.2%
2022$-2.38M+6.5%
2021$-2.55M-281.3%
2020$1.41M+201.6%
2019$-1.38M+38.4%
2018$-2.25M-418.5%
2017$705060.00+219.5%
2016$-589881.00-